published patent: Diazene-bridged crown ether lithium compounds and methods for their use

TitleDiazene-bridged crown ether lithium compounds and methods for their use
Priority Date2005-12-21 US 11/313513
2004-12-22 US 10/638100P
Inventors
Issue Date2007
Citation
US Published patent application US 2007298127. Washington, DC: US Patent and Trademark Office (USPTO), 2007 How to Cite?
AbstractThis invention provides a method for treating an eye disease in a patient comprising: providing a photosensitive prodrug that releases upon exposure to light an active ingredient to treat the eye disease; administering the prodrug in a pharmaceutically accepted vehicle to the subject, and exposing the eye of the subject to an external light source to cause the prodrug to release the active ingredient. This invention also provides a composition for the treatment of glaucoma, comprising a compound containing a lithium ion-chelated in a crown ether- or aza-crown ether-containing chromene or diazene derivative and a pharmaceutically acceptable carrier.
Persistent Identifierhttp://hdl.handle.net/10722/176947

 

DC FieldValueLanguage
dc.date.accessioned2012-11-30T08:38:49Z-
dc.date.available2012-11-30T08:38:49Z-
dc.date.issued2007-
dc.identifier.citationUS Published patent application US 2007298127. Washington, DC: US Patent and Trademark Office (USPTO), 2007en_HK
dc.identifier.urihttp://hdl.handle.net/10722/176947-
dc.description.abstractThis invention provides a method for treating an eye disease in a patient comprising: providing a photosensitive prodrug that releases upon exposure to light an active ingredient to treat the eye disease; administering the prodrug in a pharmaceutically accepted vehicle to the subject, and exposing the eye of the subject to an external light source to cause the prodrug to release the active ingredient. This invention also provides a composition for the treatment of glaucoma, comprising a compound containing a lithium ion-chelated in a crown ether- or aza-crown ether-containing chromene or diazene derivative and a pharmaceutically acceptable carrier.en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documentsen_US
dc.titleDiazene-bridged crown ether lithium compounds and methods for their useen_HK
dc.typePatenten_US
dc.description.naturepublished_or_final_versionen_US
dc.contributor.inventorVanhoutte, PMGRen_HK
dc.contributor.inventorChe, CMen_HK
dc.contributor.inventorSo, KFen_HK
dc.contributor.inventorSham Iona H.Ten_HK
patents.identifier.applicationUS 11/313513en_HK
patents.description.assigneeTHE UNIVERSITY OF HONG KONGen_HK
patents.description.countryUnited States of Americaen_HK
patents.date.publication2007-12-27en_HK
patents.identifier.hkutechidChm-2004-00168-1-
patents.date.application2005-12-21en_HK
patents.date.priority2005-12-21 US 11/313513en_HK
patents.date.priority2004-12-22 US 10/638100Pen_HK
patents.description.ccUSen_HK
patents.identifier.publicationUS 2007298127en_HK
patents.relation.familyCN 101115489 (A) 2008-01-30en_HK
patents.relation.familyDE 112005003183 (T5) 2007-11-08en_HK
patents.relation.familyGB 2437456 (A) 2007-10-24en_HK
patents.relation.familyJP 2008524268 (A) 2008-07-10en_HK
patents.relation.familyUS 2007298127 (A1) 2007-12-27en_HK
patents.relation.familyUS 7468434 (B2) 2008-12-23en_HK
patents.relation.familyWO 2006066511 (A1) 2006-06-29en_HK
patents.description.kindA1en_HK
patents.typePatent_publisheden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats